Literature DB >> 11752513

An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study.

C T Ravirajan1, L Rowse, J R MacGowan, D A Isenberg.   

Abstract

OBJECTIVE: To establish the correlation between lupus nephritis-associated autoantibody levels and the presence/activity of lupus nephritis and global disease activity using cross-sectional data in patients with systemic lupus erythematosus (SLE).
METHODS: Disease activity was assessed using the British Isles Lupus Assessment Group (BILAG) index. Antibody levels against single-stranded DNA (ssDNA), double-stranded DNA (dsDNA), histones, nucleosomes and heparan sulphate (HS) were analysed by ELISA in SLE patients with (n=11) and without (n=22) nephritis and in normal controls (n=21). Antibody subclasses were also analysed.
RESULTS: Higher levels of anti-dsDNA and anti-HS antibodies were found in patients with lupus nephritis, the level of anti-HS antibodies correlating with the BILAG renal score. Predominant subclasses were IgG1 and IgG3 for dsDNA antibodies, IgG2 for anti-nucleosome antibodies, and IgG2 and IgG3 for anti-HS antibodies.
CONCLUSION: Correlation was demonstrated between antibodies to dsDNA, ssDNA, histones, nucleosomes and HS. There is a strong correlation between the level of anti-HS antibodies and disease activity in patients with lupus nephritis as measured by BILAG.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11752513     DOI: 10.1093/rheumatology/40.12.1405

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  24 in total

Review 1.  Lupus nephritis in Colombians: contrasts and comparisons with other populations.

Authors:  Juan-Manuel Anaya; Carlos Cañas; Rubén D Mantilla; Ricardo Pineda-Tamayo; Gabriel J Tobón; Catalina Herrera-Diaz; Diego M Rendón; Adriana Rojas-Villarraga; Mauricio Uribe
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

2.  Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus.

Authors:  A E M van Nieuwenhuijze; T van Lopik; R J T Smeenk; L A Aarden
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

Authors:  E Ortqvist; B Brooks-Worrell; K Lynch; J Radtke; L M Bekris; I Kockum; C-D Agardh; C M Cilio; A L Lethagen; B Persson; A Lernmark; J Reichow; S Oak; J P Palmer; C S Hampe
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

4.  Antinucleosome in systemic lupus erythematosus. A study in a Brazilian population.

Authors:  G A Sardeto; L M Simas; T S Skare; R M Nisihara; S R R Utiyama
Journal:  Clin Rheumatol       Date:  2011-11-18       Impact factor: 2.980

5.  Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity.

Authors:  Sladjana Andrejevic; Ivica Jeremic; Mirjana Sefik-Bukilica; Milos Nikolic; Biljana Stojimirovic; Branka Bonaci-Nikolic
Journal:  Clin Rheumatol       Date:  2013-07-16       Impact factor: 2.980

6.  Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.

Authors:  G S Alarcón; J Calvo-Alén; G McGwin; A G Uribe; S M A Toloza; J M Roseman; M Fernández; B J Fessler; L M Vilá; C Ahn; F K Tan; J D Reveille
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

7.  Anti-chromatin and anti-histone antibodies in Egyptian patients with systemic lupus erythematosus.

Authors:  Adel A Shabana; Atef E El-Ghawet; Shereen A Machaly; Ekbal M Abu Hashim; Basma A El-Kady; Reham Shaat
Journal:  Clin Rheumatol       Date:  2009-03-14       Impact factor: 2.980

Review 8.  Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.

Authors:  Noam Jacob; William Stohl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

9.  Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus.

Authors:  M Petri; S Singh; H Tesfasyone; R Dedrick; K Fry; Pg Lal; G Williams; Jw Bauer; Pk Gregersen; Tw Behrens; Ec Baechler
Journal:  Lupus       Date:  2009-10       Impact factor: 2.911

10.  High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis.

Authors:  J F Carvalho; V S T Viana; E F Borba; A P do Nascimento; E P Leon; L A Testagrossa; R T Barros; E Bonfá
Journal:  Clin Rheumatol       Date:  2008-06-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.